Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Robert Schoen, University of Pittsburgh

ClinicalTrials.gov Identifier:

NCT00773097

First received: October 15, 2008

Last updated: January 16, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2012
Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)

Publications: